Search Results - "Gundle, K.R."

A Phase 0 Master Protocol Utilizing a Novel Intratumoral Microdosing Approach for Simultaneously Evaluating Multiple Drugs and Drug Combinations in Patients with Solid Tumors by Ow, T.J., Mehta, V., Gersten, A.J., Newman, J.G., Maki, R.G., Gundle, K.R., Clayburgh, D.R., Li, R.J., Porosnicu, M., Nathan, C.A.O., Hatton, B.A., Sottero, K.H.W., Kung, G., Grenley, M.O., Anderson, K., Klinghoffer, R.A.

“…Tumor responses to cancer treatments are highly context-specific and often involve complex interactions between the anti-cancer therapy, genetically diverse…”
Get full text

A phase II study of preoperative chemoradiation plus sorafenib (S) for high-risk extremity soft tissue sarcomas (STS) by Ryan, C.W., Davis, L.E., Doung, Y.-C., Davis, J.L., Hung, A.Y., Hayden, J.B., Gundle, K.R., Vetto, J.T., Mansoor, A., Beckett, B.R., Norr, P., Bertolone-Smith, S., Huang, W.

Get full text